Tenet Healthcare Corporation (THC) Stock Price, News, Analysis

Technical Score (1D)

BUY

News Sentiment

BULLISH

Wells Fargo’s latest research note upgrades Tenet Healthcare to an Overweight rating and lifts its price target from $213 to $231, signaling a stronger conviction in the company’s earnings trajectory. The upgrade stems from the firm’s recent operational improvements and a projected uptick in revenue, which analysts believe will translate into higher profitability over the next few quarters. This rating shift is likely to bolster investor confidence, potentially increasing demand for THC shares as traders adjust their portfolios to reflect the new outlook. The higher price target also suggests a broader upside potential, which may attract short‑term traders looking for a catalyst. In the coming days, the market will be keenly watching Tenet’s next earnings release, as it will confirm whether the projected earnings growth materializes. Additionally, any shifts in healthcare reimbursement policies—particularly changes in Medicare or Medicaid payment structures—could materially affect Tenet’s revenue mix and valuation. Traders should also keep an eye on the company’s cost‑control initiatives, as they are a key driver of the improved earnings outlook. Finally, monitoring the broader healthcare sector’s sentiment will help gauge whether the Overweight upgrade will ripple through peers or remain isolated to Tenet.

THC|Company Info

Sector

Healthcare

Industry

Medical Care Facilities

Exchange

NYQ

Country

United States

Website

tenethealth.com

Symbol

THC

Description

Tenet Healthcare Corporation is a U.S.-based healthcare services provider operating through two primary segments: Hospital Operations and Services, and Ambulatory Care. The company's core value proposition lies in its comprehensive network of acute care hospitals, offering a wide array of services including surgery, radiology, and specialized treatments for various conditions. These hospitals also provide intensive care, specialized surgical procedures, and tertiary care services. Furthermore, Tenet expands its reach through ambulatory surgery centers, urgent care facilities, and imaging centers, providing convenient access to outpatient care. Founded in 1967, the company's diversified service offerings and extensive physical footprint are key elements of its competitive positioning within the healthcare landscape.

THC|Earnings Snapshot

Earnings Summary

Tenet Healthcare Corporation operates a diversified network of acute care hospitals and ambulatory surgery centers, delivering a broad spectrum of medical services that places it firmly within the medical care facilities sector. The company’s most recent quarterly results show a robust performance, with Q4 2025 revenue rising to $5.527 billion from $5.072 billion in Q4 2024 and EPS increasing from $3.44 to $4.70, both surpassing analyst expectations of $5.5266 billion and $4.0934 respectively; the Q4 2024 earnings also beat the $2.83235 estimate. Historically, Tenet has consistently outperformed estimates in the two quarters reported, and its revenue growth has been steady, though the company’s cost base is expanding, raising questions about long‑term margin sustainability. Recent analyst commentary highlights a surge in investor attention, with Barclays upgrading Tenet to Overweight and raising its price target to $240, while concerns over less favorable nurse retirement benefits have surfaced, potentially impacting labor costs and recruitment; these developments may influence the company’s operating margins and are likely to be scrutinized in the upcoming July 24 earnings release. Investors should watch for any adjustments to nurse benefit policies, updates on admission growth, and the company’s guidance for Q2 2026, as these factors will be critical in assessing Tenet’s ability to maintain earnings momentum amid rising labor and operational expenses.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$4.22	-	-
Q4'25	$4.09	$4.70	+14.8%
Q4'24	$2.83	$3.44	+21.5%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$5.5B	-	-
Q4'25	$5.5B	$5.5B	+0.0%
Q4'24	-	$5.1B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

Market Data

THC Stock Snapshot

THC is currently trading at $195.00, giving Tenet Healthcare Corporation a market cap of 17.38B and a P/E ratio of 10.2. Today's range spans $194.08–$205.94, with shares opening at $204.09 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 77/100 (BUY) with a news sentiment reading of 70/100.

Over the past year THC has traded between $146.60 and $247.21 - the current price is +33.0% off the 52-week low and -21.1% from the high. 29 analysts cover the stock with a Buy consensus and a mean 12-month target of $244.19 (range $210.00–$288.00), implying upside of +25.2%.

Tenet Healthcare Corporation (THC) is a large-cap in Healthcare with 17.38B in market cap, and the current setup is one of the cleaner bullish reads in the space. Technical score: 77/100 (BUY). Sentiment: bullish at 70/100. Price: $195.00 (in the middle of its 52-week range). The current P/E ratio stands at 10.2. The 52-week range of $146.60–$247.21 provides structural context - and the current technical/sentiment alignment is the type of setup that attracts both momentum and growth-oriented capital.

The combination of a BUY signal (77/100) and bullish news sentiment (70/100) puts THC on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 17.38B in Healthcare market cap without immediately moving the stock. At $195.00 (in the middle of its 52-week range in the $146.60–$247.21 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.

News Sentiment Analysis

Sentiment gathered from recent headlines

70/100

Strong NegativeNeutralStrong Positive

BULLISH

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Wells Fargo analyst Stephen Baxter has upgraded Tenet Healthcare (THC) to an Overweight rating and increased the price target from $213 to $231. The upgrade reflects confidence in the company's earnings outlook and operational improvements. The new target suggests a potential upside for investors. Traders should monitor upcoming earnings releases and any changes in healthcare reimbursement policies that could impact THC's valuation.

What did this article say?

Tenet Healthcare (THC) slipped 1.22% to $204.25, lagging the broader market. The decline follows a 19.4% gain earlier in the year, but the stock remains under pressure as investors await the July 24 earnings report. Analysts project a quarterly EPS of $4.08 and revenue of $5.39 billion, with full‑year guidance of $17.61 per share and $22.02 billion in sales. The company’s performance will be scrutinized for any upside or downside surprises.

What did this article say?

Tenet Healthcare Corporation (THC) has attracted significant attention from Zacks.com users, signaling growing investor interest. Analysts highlight upcoming earnings and operational initiatives as potential catalysts. The market’s focus may influence short‑term price dynamics, making THC a watchable play for traders. Understanding these drivers is essential for positioning in the near term.

What did this article say?

Barclays analyst Andrew Mok has upgraded Tenet Healthcare (NYSE:THC) to an Overweight rating and increased the price target from $238 to $240, reflecting a more optimistic earnings outlook. The rating change signals confidence in the company’s ability to navigate the healthcare sector’s evolving landscape. Traders should note the upward revision as a bullish indicator for short‑term price movement.

What did this article say?

New analysis indicates Tenet Healthcare’s nurses receive less favorable retirement benefits compared to nonprofit and public sector peers, potentially affecting recruitment and retention. This benefit gap could lead to higher labor costs and operational instability. Investors should watch for any changes to benefit policy or related regulatory scrutiny.

What did this article say?

Argus Research has upgraded THC to a BUY rating, indicating a positive outlook for the company. The upgrade reflects confidence in THC’s earnings prospects and strategic positioning within the cannabis sector. Investors should monitor the company’s upcoming earnings release and guidance for further confirmation of the rating’s rationale.

What did this article say?

Tenet Healthcare (THC) closed at $208.82, reflecting a 1.28% gain from the previous day. The stock outperformed the S&P 500, which fell 0.45%, as well as the Dow and Nasdaq. The gain highlights THC’s resilience amid broader market weakness.

What did this article say?

For-profit hospitals such as THC provide nurses only a 401(k), preventing the dual‑stack retirement strategy that combines a 403(b) and a 457(b). This limitation means THC nurses cannot shield up to $49,000 of pretax income in a single year, a benefit available at nonprofit or government facilities. The shortfall may affect nurse retention and overall compensation competitiveness. The article highlights the regulatory gap and the potential financial impact on THC’s workforce.

What did this article say?

THC is benefiting from rising admissions and robust ambulatory care expansion, driving earnings momentum. The company’s cost base is climbing, raising questions about sustainability. Investors should monitor expense trends and admission growth to gauge future performance.

What did this article say?

Zacks ranks Tenet Healthcare (THC) as a Buy with an A in Value, highlighting its strong value profile. The company’s PEG ratio of 0.81 is well below the industry average of 1.87, suggesting potential upside. This favorable valuation, combined with a solid earnings outlook, positions THC as an attractive pick for value investors. Traders should monitor the upcoming earnings release for guidance and any changes to the Zacks Rank or Value score.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

THC·Tenet Healthcare Corporation

EPS

Revenue

THC Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Discover More

News Sentiment Analysis

Recent News Coverage

Discover More